Dolon Ltd
Adam Hutchings has extensive experience in the healthcare and market access sectors, currently serving as Managing Partner at Dolon Ltd since January 2014. Prior to this role, Adam was a Partner at Global Market Access Solutions from June 2009 to December 2013. Earlier career positions include Director of European Health Outcomes at Baxter from January 2007 to May 2009, Health Outcomes Manager at GlaxoSmithKline from 2003 to 2007, and Senior Health Economist at Aventis from 2001 to 2003. Adam Hutchings possesses a strong background in health economics and outcomes research, contributing to various organizations over the years.
This person is not in any teams
This person is not in any offices
Dolon Ltd
Dolon is a leading, strategic consultancy specialising in pricing and market access for rare disease medicines. We partner and provide strategic guidance to global and national pharmaceutical companies on a variety of market access and policy issues globally. Our goal is to ensure that effective rare disease treatments are made accessible to the patients who need them, in a way that is sustainable for both the pharmaceutical industry and society. Our market access specialists deliver solutions at a therapy, disease, portfolio and industry level to realise success throughout the product life cycle. We provide services in the following areas: • Value, Price and Access • Market Access Policy • Data and Analytics Headquartered in London, and with offices globally, we are a team of enthusiastic and intellectually curious individuals who share a passion for collaboration and solving complex problems.